BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2393885)

  • 21. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.
    Cansick JC; Lennon R; Cummins CL; Howie AJ; McGraw ME; Saleem MA; Tizard EJ; Hulton SA; Milford DV; Taylor CM
    Nephrol Dial Transplant; 2004 Nov; 19(11):2769-77. PubMed ID: 15385635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
    Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
    Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Extracapillary glomerulonephritis].
    Rifle G; Chevet D; Justrabo E
    Rev Prat; 1991 Nov; 41(24):2437-45. PubMed ID: 1803455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis.
    Paydas S; Balal M; Tanriverdi K; Sertdemir Y; Baslamisli F
    Ren Fail; 2007; 29(7):779-84. PubMed ID: 17994443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy.
    Sorger K; Gessler M; Hübner FK; Köhler H; Olbing H; Schulz W; Thoenes GH; Thoenes W
    Clin Nephrol; 1987 Mar; 27(3):111-24. PubMed ID: 3552342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial foam cells in renal biopsies: an aid in differentiating idiopathic membranoproliferative glomerulonephritis (type I) and membranoproliferative glomerulonephritis associated with systemic lupus erythematosus.
    Poucell S; Thorner P; Balfe JW; Baumal R
    Child Nephrol Urol; 1988-1989; 9(1-2):106-11. PubMed ID: 3251613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.
    Kazama I; Matsubara M; Ejima Y; Michimata M; Suzuki M; Miyama N; Sato A; Sato H; Ito S
    Clin Exp Nephrol; 2005 Mar; 9(1):62-8. PubMed ID: 15830276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Membranous glomerulonephritis].
    Polenaković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():18-25. PubMed ID: 9102898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histopathologic factors with prognostic significance in mesangial proliferative glomerulonephritis].
    García del Moral R; Lázaro Damas A; Gómez Morales M; Alvaro Naranjo T; Navarro Martínez N; Navas Parejo A; Aguilar Peña D
    Med Clin (Barc); 1989 Apr; 92(16):608-11. PubMed ID: 2747323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Idiopathic membranoproliferative glomerulonephritis (structural-functional relationship)].
    Banković-Calić N; Sindjić M; Milosavljević M; Stojković D; Velimirović D; Djukonović Lj
    Srp Arh Celok Lek; 1996; 124 Suppl 1():26-9. PubMed ID: 9102921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of hypertension in patients with mesangioproliferative glomerulonephritis].
    Pap I; Gärtner U
    Z Arztl Fortbild (Jena); 1988; 82(10):461-2. PubMed ID: 3218263
    [No Abstract]   [Full Text] [Related]  

  • 36. A descriptive study of individuals with membranoproliferative glomerulonephritis.
    Lu DF; McCarthy AM; Lanning LD; Delaney C; Porter C
    Nephrol Nurs J; 2007; 34(3):295-302; quiz 303. PubMed ID: 17644874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kidney involvement in rheumatoid arthritis].
    Konstantinova L
    Vutr Boles; 1989; 28(6):82-6. PubMed ID: 2633486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.
    Schmitt H; Bohle A; Reineke T; Mayer-Eichberger D; Vogl W
    Nephron; 1990; 55(3):242-50. PubMed ID: 2370922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term prognosis in idiopathic membranoproliferative glomerulonephritis.
    Pedersen RS
    Scand J Urol Nephrol; 1995 Sep; 29(3):265-72. PubMed ID: 8578267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.